Search Count: 4
 |
Ethr From Mycobacterium Tuberculosis In Complex With Compound Bdm31379
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2012-01-11 Classification: TRANSCRIPTION/TRANSCRIPTION INHIBITOR Ligands: LL3 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2012-01-11
Ligands: LL3
 |
Ethr From Mycobacterium Tuberculosis In Complex With Compound Bdm31369
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-01-11 Classification: TRANSCRIPTION/TRANSCRIPTION INHIBITOR Ligands: LL4 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2012-01-11
Ligands: LL4
 |
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement And Structure-Based Drug Design To Solve Pharmacokinetic Issues In A Series Of Potent 1,2,4-Oxadiazole Ethr Inhibitors.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2011-12-07 Classification: TRANSCRIPTION REPRESSOR/INHIBITOR Ligands: 3SE |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: 3SE
 |
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement And Structure-Based Drug Design To Solve Pharmacokinetic Issues In A Series Of Potent 1,2,4-Oxadiazole Ethr Inhibitors.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2011-12-07 Classification: TRANSCRIPTION REPRESSOR/INHIBITOR Ligands: 3SF |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: 3SF